Results 171 to 180 of about 606,469 (298)
Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham +7 more
wiley +1 more source
ABSTRACT Background Poststroke fatigue (PSF) and frailty share substantial overlap in their manifestations, yet previous research has yielded conflicting results due to the use of heterogeneous frailty assessment tools. Objective To evaluate the independent impact of frailty on PSF using a unified measurement system (Tilburg Frailty Indicator, TFI ...
Chuan‐Bang Chen +6 more
wiley +1 more source
Persistence of NPi differential predicts outcome at intensive care unit discharge: a single-center retrospective analysis. [PDF]
Zerbi SM +6 more
europepmc +1 more source
Persistence and Degradation of Pendimethalin and Anilofos in Flooded versus Non-Flooded Soils
K. Arvind +2 more
openalex +1 more source
ABSTRACT Objective Epilepsy is increasingly associated with immune dysregulation and inflammation. The T cell receptor (TCR), a key mediator of adaptive immunity, shows repertoire alterations in various immune‐mediated diseases. The unique TCR sequence serves as a molecular barcode for T cells, and clonal expansion accompanied by reduced overall TCR ...
Yong‐Won Shin +12 more
wiley +1 more source
Echinocandin tolerance and persistence <i>in vitro</i> are regulated by calcineurin signaling in <i>Candida glabrata</i>. [PDF]
Harrington AA +2 more
europepmc +1 more source
Further Observations on the Persistence of Antibody in Adolescents after a Third Dose of Killed Poliomyelitis Vaccine [PDF]
E. J. C. Kendall +2 more
openalex +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source
How Adherence Shapes Persistence in Idiopathic Pulmonary Fibrosis Treatment: A Call for Real-World Insight. [PDF]
Borrás-Blasco J +2 more
europepmc +1 more source

